Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
15.29
+0.56 (3.80%)
At close: Sep 14, 2026, 4:00 PM EDT
15.16
-0.13 (-0.85%)
After-hours: Sep 14, 2026, 7:30 PM EDT
ARCT Market Cap
ARCT has a market cap or net worth of $434.59 million as of September 14, 2026. Its market cap has decreased by -7.59% in one year.
Market Cap
434.59M
Enterprise Value
266.04M
1-Year Change
-7.59%
Ranking
Category
Stock Price
$15.29
ChartMarket Cap Chart
Since May 22, 2013, ARCT's market cap has increased from $103.00M to $434.59M, an increase of 321.93%. That is a compound annual growth rate of 11.41%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 14, 2026 | 434.59M | 149.48% |
| Dec 31, 2025 | 174.20M | -62.11% |
| Dec 31, 2024 | 459.70M | -45.44% |
| Dec 29, 2023 | 842.60M | 87.54% |
| Dec 30, 2022 | 449.30M | -53.95% |
| Dec 31, 2021 | 975.60M | -8.18% |
| Dec 31, 2020 | 1.06B | 546.29% |
| Dec 31, 2019 | 164.40M | 238.97% |
| Dec 31, 2018 | 48.50M | 54.95% |
| Dec 29, 2017 | 31.30M | -45.94% |
| Dec 30, 2016 | 57.90M | -32.75% |
| Dec 31, 2015 | 86.10M | 69.16% |
| Dec 31, 2014 | 50.90M | -79.27% |
| Dec 31, 2013 | 245.50M | 138.35% |
| May 22, 2013 | 103.00M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kyverna Therapeutics | 448.98M |
| Rezolute | 440.85M |
| C4 Therapeutics | 431.82M |
| Inhibikase Therapeutics | 426.06M |
| Atea Pharmaceuticals | 425.89M |
| Benitec Biopharma | 418.78M |
| Editas Medicine | 414.67M |
| Larimar Therapeutics | 409.18M |